BioNTech SE
BNTX
$93.66
$0.320.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -76.93% | -76.39% | -26.46% | 29.76% | -786.05% |
| Total Depreciation and Amortization | 75.70% | 23.80% | 19.56% | -21.22% | -15.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 476.40% | 286.49% | 85.18% | -109.44% | 30.59% |
| Change in Net Operating Assets | 90.38% | -50.42% | -92.20% | -135.87% | -90.15% |
| Cash from Operations | 458.90% | 193.17% | -114.59% | -157.75% | -104.28% |
| Capital Expenditure | 29.00% | 36.19% | 40.68% | 24.21% | -4.31% |
| Sale of Property, Plant, and Equipment | 257.22% | 301.35% | 859.51% | 907.76% | -- |
| Cash Acquisitions | 473.15% | -- | -- | 77.47% | 77.47% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -172.30% | -55.36% | 119.61% | 132.28% | 122.38% |
| Cash from Investing | -183.35% | -32.79% | 113.82% | 124.69% | 116.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.51% | -25.49% | 9.82% | 19.27% | -33.42% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 73.24% | -20.42% | 8.70% | 88.05% | 89.67% |
| Foreign Exchange rate Adjustments | -99.00% | -289.94% | 88.51% | 106.83% | -137.46% |
| Miscellaneous Cash Flow Adjustments | -40.93% | 136.56% | -109.51% | -84.54% | -44.69% |
| Net Change in Cash | -125.68% | -18.60% | 111.43% | 96.61% | 137.21% |